The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Stem Cell Umbilical Cord Blood-Global Market Insights and Sales Trends 2024
Synopsis
Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.
The global Stem Cell Umbilical Cord Blood market size is expected to reach US$ 129860 million by 2029, growing at a CAGR of 31.0% from 2023 to 2029. The market is mainly driven by the significant applications of Stem Cell Umbilical Cord Blood in various end use industries. The expanding demands from the Cancer/ Oncology Diseases, Chronic Leukemia, Myelodysplastic Syndrome and Blood Diseases, are propelling Stem Cell Umbilical Cord Blood market. Public Cord Blood Banks, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Private Cord Blood Banks segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Stem Cell Umbilical Cord Blood, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Stem Cell Umbilical Cord Blood market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Stem Cell Umbilical Cord Blood market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Stem Cell Umbilical Cord Blood sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Stem Cell Umbilical Cord Blood covered in this report include Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics, Athersys, Geron Corporation and Neostem, etc.
The global Stem Cell Umbilical Cord Blood market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics
Athersys
Geron Corporation
Neostem
Global Stem Cell Umbilical Cord Blood market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stem Cell Umbilical Cord Blood market, Segment by Type:
Public Cord Blood Banks
Private Cord Blood Banks
Global Stem Cell Umbilical Cord Blood market, by Application
Cancer/ Oncology Diseases
Chronic Leukemia
Myelodysplastic Syndrome
Blood Diseases
Beta Thalassemia
Sickle Cell Disease
Wiskott-Aldrich
Hurler Syndrome
Sanfilippo Syndrome
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Stem Cell Umbilical Cord Blood companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.
The global Stem Cell Umbilical Cord Blood market size is expected to reach US$ 129860 million by 2029, growing at a CAGR of 31.0% from 2023 to 2029. The market is mainly driven by the significant applications of Stem Cell Umbilical Cord Blood in various end use industries. The expanding demands from the Cancer/ Oncology Diseases, Chronic Leukemia, Myelodysplastic Syndrome and Blood Diseases, are propelling Stem Cell Umbilical Cord Blood market. Public Cord Blood Banks, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Private Cord Blood Banks segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Stem Cell Umbilical Cord Blood, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Stem Cell Umbilical Cord Blood market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Stem Cell Umbilical Cord Blood market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Stem Cell Umbilical Cord Blood sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Stem Cell Umbilical Cord Blood covered in this report include Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics, Athersys, Geron Corporation and Neostem, etc.
The global Stem Cell Umbilical Cord Blood market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics
Athersys
Geron Corporation
Neostem
Global Stem Cell Umbilical Cord Blood market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stem Cell Umbilical Cord Blood market, Segment by Type:
Public Cord Blood Banks
Private Cord Blood Banks
Global Stem Cell Umbilical Cord Blood market, by Application
Cancer/ Oncology Diseases
Chronic Leukemia
Myelodysplastic Syndrome
Blood Diseases
Beta Thalassemia
Sickle Cell Disease
Wiskott-Aldrich
Hurler Syndrome
Sanfilippo Syndrome
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Stem Cell Umbilical Cord Blood companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Stem Cell Umbilical Cord Blood
1.1 Stem Cell Umbilical Cord Blood Market Overview
1.1.1 Stem Cell Umbilical Cord Blood Product Scope
1.1.2 Stem Cell Umbilical Cord Blood Market Status and Outlook
1.2 Global Stem Cell Umbilical Cord Blood Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Stem Cell Umbilical Cord Blood Market Size by Region (2018-2029)
1.4 Global Stem Cell Umbilical Cord Blood Historic Market Size by Region (2018-2023)
1.5 Global Stem Cell Umbilical Cord Blood Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Stem Cell Umbilical Cord Blood Market Size (2018-2029)
1.6.1 North America Stem Cell Umbilical Cord Blood Market Size (2018-2029)
1.6.2 Europe Stem Cell Umbilical Cord Blood Market Size (2018-2029)
1.6.3 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size (2018-2029)
1.6.4 Latin America Stem Cell Umbilical Cord Blood Market Size (2018-2029)
1.6.5 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size (2018-2029)
2 Stem Cell Umbilical Cord Blood Market by Type
2.1 Introduction
2.1.1 Public Cord Blood Banks
2.1.2 Private Cord Blood Banks
2.2 Global Stem Cell Umbilical Cord Blood Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Stem Cell Umbilical Cord Blood Historic Market Size by Type (2018-2023)
2.2.2 Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Stem Cell Umbilical Cord Blood Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Stem Cell Umbilical Cord Blood Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Stem Cell Umbilical Cord Blood Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Stem Cell Umbilical Cord Blood Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Stem Cell Umbilical Cord Blood Revenue Breakdown by Type (2018-2029)
3 Stem Cell Umbilical Cord Blood Market Overview by Application
3.1 Introduction
3.1.1 Cancer/ Oncology Diseases
3.1.2 Chronic Leukemia
3.1.3 Myelodysplastic Syndrome
3.1.4 Blood Diseases
3.1.5 Beta Thalassemia
3.1.6 Sickle Cell Disease
3.1.7 Wiskott-Aldrich
3.1.8 Hurler Syndrome
3.1.9 Sanfilippo Syndrome
3.2 Global Stem Cell Umbilical Cord Blood Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Stem Cell Umbilical Cord Blood Historic Market Size by Application (2018-2023)
3.2.2 Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Stem Cell Umbilical Cord Blood Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Stem Cell Umbilical Cord Blood Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Stem Cell Umbilical Cord Blood Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Stem Cell Umbilical Cord Blood Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Stem Cell Umbilical Cord Blood Revenue Breakdown by Application (2018-2029)
4 Stem Cell Umbilical Cord Blood Competition Analysis by Players
4.1 Global Stem Cell Umbilical Cord Blood Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Stem Cell Umbilical Cord Blood as of 2022)
4.3 Date of Key Players Enter into Stem Cell Umbilical Cord Blood Market
4.4 Global Top Players Stem Cell Umbilical Cord Blood Headquarters and Area Served
4.5 Key Players Stem Cell Umbilical Cord Blood Product Solution and Service
4.6 Competitive Status
4.6.1 Stem Cell Umbilical Cord Blood Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Advanced Cell Technology
5.1.1 Advanced Cell Technology Profile
5.1.2 Advanced Cell Technology Main Business
5.1.3 Advanced Cell Technology Stem Cell Umbilical Cord Blood Products, Services and Solutions
5.1.4 Advanced Cell Technology Stem Cell Umbilical Cord Blood Revenue (US$ Million) & (2018-2023)
5.1.5 Advanced Cell Technology Recent Developments
5.2 California Stem Cell
5.2.1 California Stem Cell Profile
5.2.2 California Stem Cell Main Business
5.2.3 California Stem Cell Stem Cell Umbilical Cord Blood Products, Services and Solutions
5.2.4 California Stem Cell Stem Cell Umbilical Cord Blood Revenue (US$ Million) & (2018-2023)
5.2.5 California Stem Cell Recent Developments
5.3 Cytori Therapeutics
5.3.1 Cytori Therapeutics Profile
5.3.2 Cytori Therapeutics Main Business
5.3.3 Cytori Therapeutics Stem Cell Umbilical Cord Blood Products, Services and Solutions
5.3.4 Cytori Therapeutics Stem Cell Umbilical Cord Blood Revenue (US$ Million) & (2018-2023)
5.3.5 Mesoblast Limited Recent Developments
5.4 Mesoblast Limited
5.4.1 Mesoblast Limited Profile
5.4.2 Mesoblast Limited Main Business
5.4.3 Mesoblast Limited Stem Cell Umbilical Cord Blood Products, Services and Solutions
5.4.4 Mesoblast Limited Stem Cell Umbilical Cord Blood Revenue (US$ Million) & (2018-2023)
5.4.5 Mesoblast Limited Recent Developments
5.5 Opexa Therapeutics
5.5.1 Opexa Therapeutics Profile
5.5.2 Opexa Therapeutics Main Business
5.5.3 Opexa Therapeutics Stem Cell Umbilical Cord Blood Products, Services and Solutions
5.5.4 Opexa Therapeutics Stem Cell Umbilical Cord Blood Revenue (US$ Million) & (2018-2023)
5.5.5 Opexa Therapeutics Recent Developments
5.6 Athersys
5.6.1 Athersys Profile
5.6.2 Athersys Main Business
5.6.3 Athersys Stem Cell Umbilical Cord Blood Products, Services and Solutions
5.6.4 Athersys Stem Cell Umbilical Cord Blood Revenue (US$ Million) & (2018-2023)
5.6.5 Athersys Recent Developments
5.7 Geron Corporation
5.7.1 Geron Corporation Profile
5.7.2 Geron Corporation Main Business
5.7.3 Geron Corporation Stem Cell Umbilical Cord Blood Products, Services and Solutions
5.7.4 Geron Corporation Stem Cell Umbilical Cord Blood Revenue (US$ Million) & (2018-2023)
5.7.5 Geron Corporation Recent Developments
5.8 Neostem
5.8.1 Neostem Profile
5.8.2 Neostem Main Business
5.8.3 Neostem Stem Cell Umbilical Cord Blood Products, Services and Solutions
5.8.4 Neostem Stem Cell Umbilical Cord Blood Revenue (US$ Million) & (2018-2023)
5.8.5 Neostem Recent Developments
6 North America
6.1 North America Stem Cell Umbilical Cord Blood Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Stem Cell Umbilical Cord Blood Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Stem Cell Umbilical Cord Blood Market Dynamics
11.1 Stem Cell Umbilical Cord Blood Industry Trends
11.2 Stem Cell Umbilical Cord Blood Market Drivers
11.3 Stem Cell Umbilical Cord Blood Market Challenges
11.4 Stem Cell Umbilical Cord Blood Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
